Shaalan Beg, MD, MBA, FASCO

Oncology leaders weigh how to scale trustworthy AI platforms, align governance, and integrate care-research workflows for real-world adoption.

AI-powered trial screening helps community oncology practices identify eligible patients locally, widening access beyond academic centers and reducing barriers such as distance and logistics.

Agentic AI speeds oncology trial screening by synthesizing records and ranking candidates, while clinicians keep final eligibility and consent decisions.

Agentic AI taps electronic medical records to flag timely oncology trial candidates, fit workflow, cut clinician burden, and boost community practice enrollment.

Agentic AI in oncology distills evidence, molecular data, and guidelines to aid therapy decisions, promising smarter, context-aware cancer care.

Agentic AI streamlines oncology decisions and trial matching, cutting administrative load, flagging care gaps, and widening community access to studies.